[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100369031":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":12,"locations":18,"responsibleParty":77,"collaborators":7,"id":79,"slug":80,"hasResults":81,"nctId":82,"briefTitle":83,"officialTitle":83,"acronym":7,"eligibilityCriteria":84,"healthyVolunteers":81,"sex":85,"minAge":86,"maxAge":7,"enrollmentInfo":87,"targetDuration":90,"studyType":91,"phases":7,"briefSummary":92,"conditions":93,"keywords":96,"overallStatus":21,"whyStopped":7,"lastUpdateSubmitDate":98,"lastUpdatePostDateStruct":99,"startDateStruct":102,"completionDateStruct":104,"leadSponsor":106,"locationsCount":107},{"fullName":5,"class":6},"Duke University","OTHER",null,[9],{"name":10,"affiliation":5,"role":11},"Joseph Salama, MD","PRINCIPAL_INVESTIGATOR",[13],{"name":14,"role":15,"phone":16,"phoneExt":7,"email":17},"Clinical Trials Office","CONTACT","(919) 668 3726","RadOnc-Clinical_Trials@dm.duke.edu",[19,36,50,58,69],{"facility":20,"status":21,"city":22,"state":23,"zip":24,"country":25,"countryCode":26,"cosmosGeoPoint":27,"geoPoint":32,"contacts":33},"Duke Cancer Institute Cary","RECRUITING","Cary","North Carolina","27518","United States","US",{"type":28,"coordinates":29},"Point",[30,31],-78.78112,35.79154,{"lat":31,"lon":30},[34],{"name":14,"role":15,"phone":35,"phoneExt":7,"email":17},"919-668-3726",{"facility":37,"status":21,"city":38,"state":23,"zip":39,"country":25,"countryCode":26,"cosmosGeoPoint":40,"geoPoint":44,"contacts":45},"Durham Veterans Administration Health Care System (DVAHCS)","Durham","27705",{"type":28,"coordinates":41},[42,43],-78.89862,35.99403,{"lat":43,"lon":42},[46,49],{"name":47,"role":15,"phone":7,"phoneExt":7,"email":48},"Josephine Gaston, RN","josephine.gaston@va.gov",{"name":10,"role":11,"phone":7,"phoneExt":7,"email":7},{"facility":51,"status":21,"city":38,"state":23,"zip":52,"country":25,"countryCode":26,"cosmosGeoPoint":53,"geoPoint":55,"contacts":56},"Duke University Medical Center","27710",{"type":28,"coordinates":54},[42,43],{"lat":43,"lon":42},[57],{"name":14,"role":15,"phone":35,"phoneExt":7,"email":17},{"facility":59,"status":21,"city":60,"state":23,"zip":61,"country":25,"countryCode":26,"cosmosGeoPoint":62,"geoPoint":66,"contacts":67},"Duke Women's Cancer Care Raleigh","Raleigh","27607",{"type":28,"coordinates":63},[64,65],-78.63861,35.7721,{"lat":65,"lon":64},[68],{"name":14,"role":15,"phone":35,"phoneExt":7,"email":17},{"facility":70,"status":21,"city":60,"state":23,"zip":71,"country":25,"countryCode":26,"cosmosGeoPoint":72,"geoPoint":74,"contacts":75},"Duke Raleigh Hospital","27609",{"type":28,"coordinates":73},[64,65],{"lat":65,"lon":64},[76],{"name":14,"role":15,"phone":35,"phoneExt":7,"email":17},{"type":78,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100369031","role-of-ablative-radiotherapy-in-the-management-of-metastatic-disease-a-patient-data-registry-100369031",false,"NCT04085029","Role of Ablative Radiotherapy in the Management of Metastatic Disease: A Patient Data Registry","Inclusion Criteria:\n\n* Age ≥ 18 years of age\n* Radiographic evidence of metastatic disease (may include oligoprogression, oligorecurrence or oligometastasis) at the time of study enrollment\n* Planned to receive, currently receiving, or have completed hypofractionated image guided radiotherapy (ablative radiotherapy) to an extracranial site(s)\n* Patient must sign study-specific informed consent\n\nExclusion Criteria:\n\n• None","ALL","18 Years",{"count":88,"type":89},300,"ESTIMATED","10 Years","OBSERVATIONAL","The purpose of this study is to provide a registry of participants in order to assess the acute adverse event rates following ablative radiotherapy for metastatic disease.",[94,95],"Oligometastasis","Metastatic Cancer",[97],"Ablative radiotherapy","2026-02-03",{"date":100,"type":101},"2026-02-05","ACTUAL",{"date":103,"type":101},"2019-09-26",{"date":105,"type":89},"2029-09",{"name":5,"class":6},5]